Thiopoly is a Pittsburgh HealthTech company. Its product, Thio, is an IoT and sensor-based inventory platform built for infusion centers, specialty pharmacies, clinic networks and outpatient health-system sites: the settings where more care is now delivered, and which inpatient pharmacy systems were not designed for.
Thio gives pharmacy teams real-time visibility into drug inventory with no tagging, no heavy IT work and no upfront capital, sold as a subscription. A case study published in Pharmacy Purchasing & Products in July 2026, written by the senior director of pharmacy at the University of Rochester Medical Center, documented a 13-month smart-bin insulin deployment that reported 100% inventory accuracy across cycle counts and zero stockouts.
Founder and CEO Doug Descalzi has spent more than 20 years in medication management and health technology. Keystone Innovation Fund II announced its investment in September 2026.

We are thrilled to partner with KIF as we begin deployment of our technology and build momentum. We have a growing backlog, and access to the right capital is critical for our growth. Investment and support from KIF will allow us to continue to build and scale.
Doug Descalzi, Founder & CEO, Thiopoly
The next company on this page could be yours.
Keystone Innovation Fund II backs pre-seed and seed technology companies in, or moving to, Pennsylvania. We read every pitch.